Interactive discussion: what are the implications of SGLT2 inhibition for CV risk reduction in a multi-risk patient population?
28 August 2016 (16:00 - 16:15)
Organised by:
About the speakers
University College London, London (United Kingdom of Great Britain & Northern Ireland)
New Haven (United States of America)
2 More presentations in this session
Professor J. Deanfield (London, GB)
Professor S. Inzucchi (New Haven, US)
Access the full session
The Event
ESC Congress 2016
28 August 2016
16:00 CET
